This is a working overview of regulatory status, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-02-25 and is reviewed periodically as new material appears.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
BMA Scotland calls off a planned strike by junior doctors in Scotland while it consults its members on a revised 12.4% pay offer for 2023–24. 8 July – The Union Chain Bridge, which spans the River Tweed, linking England and Scotland, is named as an International Historic Civil Engineering Landmark. 10 July – Bus operator First Glasgow announces it is withdrawing all of its night-time services from Glasgow, doing so from 31 July. 11 July – Following his trial and conviction at Glasgow High Court, Logan Doig is sentenced to a twelve and a half year extended sentence for the rape and sexual assault of four women, and the sexual assault of a fifth. He must serve at least nine and a half years in custody and is placed on the Sex Offenders Register indefinitely. Doig's victims subsequently meet with Dorothy Bain, the Lord Advocate, to argue for a change in the way victims of sex crimes are treated in court. 12 July – Glasgow's Burrell Collection is named the 2023 Art Fund Museum of the Year. 13 July Patients are evacuated from two wards at Paisley's Royal Alexandra Hospital after Legionella bacteria is found in the water supply. Emails regarding the arrest of Peter Murrell are released and show that the Scottish Government was informed of the arrest shortly after it occurred. 14 July – Lord Advocate Dorothy Bain KC orders a review of how diversion from prosecution (referring an offender to social services rather than prosecuting them) is used in sex crime cases.
It includes the midbrain, pons, and medulla oblongata and regulates essential functions such as breathing, heart rate, and sleep. Brain ventricles A set of interconnected cavities within the brain that produce and circulate cerebrospinal fluid (CSF). Includes the lateral, third, and fourth ventricles. Brain waves Patterns of electrical activity in the brain, typically detected by electroencephalography (EEG). Brain waves are categorized by frequency, such as alpha, beta, delta, and theta waves. Brain-computer interface (BCI) A technology that enables direct communication between the brain and an external device, often used in research, prosthetics, and communication aids for individuals with disabilities. Bradykinesia Slowness of movement, often a symptom of Parkinson’s disease and other disorders involving the basal ganglia. Broca's area A region in the frontal lobe, typically in the left hemisphere, associated with the production of speech. Damage can result in Broca's aphasia, characterized by impaired speech fluency. Broca's aphasia A language disorder caused by damage to Broca's area, resulting in slow, laborious speech with relatively preserved comprehension. Brodmann areas Regions of the cerebral cortex defined by Korbinian Brodmann based on cytoarchitecture. These areas are still widely used to describe functional brain localization (e.g., Brodmann area 17 = primary visual cortex). Burst firing A pattern of rapid spikes from a neuron followed by a period of quiescence. It plays a role in sensory encoding and signal amplification in various brain circuits.
The Moon race is often analyzed as a microcosm of the Space Race's broader dynamics. Historians such as Jennifer Frost argue that if the Space Race is measured in terms of overall spaceflight capability, the Soviet Union "won it hands down." Asif A. Siddiqi, a noted space historian, provides a more nuanced view, emphasizing the Soviet Union's dominance in smaller aspects of the race to the moon, yet critical, benchmarks such as the first lunar impact, first photos of the Moon's far side, first soft lunar landing, and first lunar orbit. These accomplishments laid the groundwork for lunar exploration, though they are often overshadowed by the Apollo 11 mission. After the period of détente, the Soviet Union managed to send 18 crafts to Venus. However, this did not generate wide speculation from the western world.Before that landing [Apollo 11], there was an enormous amount of investment in the robotic exploration of the Moon, both by the Soviets and the US, in terms of all sorts of smaller benchmarks like the first lunar impact, the first pictures of the far side of the Moon, the first soft lunar landing, and the first lunar orbit. We forget, but in those little races, the Soviet Union dominated almost every benchmark, but it is forgotten as the United States won the big one.
Sources: en.wikipedia.org
=== Receiver details === In addition to triggering the broadcast signal, the output of the transmitter trigger signal was also sent to the receiver hut. Here it fed the input to a time base generator that drove the X-axis deflection plates of the CRT display. This caused the electron beam in the tube to start moving left-to-right at the instant that the transmission was completed. Due to the slow decay of the pulse, some of the transmitted signal was received on the display. This signal was so powerful it overwhelmed any reflected signal from targets, which meant that objects closer than about 5 miles (8.0 km) could not be seen on the display. To reduce this period even to this point required the receiver to be hand-tuned, selecting the decoupling capacitors and impedance of the power supplies. The receiver system, built by A.C. Cossor to a TRE design, was a multiple-stage superheterodyne. The signal from the selected antennas on the receiver towers was fed through the radiogoniometer and then into a three-stage amplifier, with each stage housed in a metal screen box to avoid interference between the stages. Each stage used a Class B amplifier arrangement of EF8s, special low noise, "aligned-grid" pentodes. The output of the initial amplifier was then sent to the intermediate frequency mixer, which extracted a user-selectable amount of the signal, 500, 200 or 50 kHz as selected by a switch on the console. The first setting allowed most of the signal through, and was used under most circumstances.
=== Fibular shaft === Another common bone graft, which is more substantial than those used for dental implants, is of the fibular shaft. After the segment of the fibular shaft has been removed normal activities such as running and jumping are permitted on the leg with the bone deficit. The grafted, vascularized fibulas have been used to restore skeletal integrity to long bones of limbs in which congenital bone defects exist and to replace segments of bone after trauma or malignant tumor invasion. The periosteum and nutrient artery are generally removed with the piece of bone so that the graft will remain alive and grow when transplanted into the new host site. Once the transplanted bone is secured into its new location it generally restores blood supply to the bone in which it has been attached.
=== Calls for regulation and reform === The British Medical Association called for a formal mechanism to hold NHS managers and healthcare administrators accountable for mismanagement, comparable to the General Medical Council's ability to strike off doctors. A neonatal consultant who had raised concerns about Letby also urged the introduction of regulation for healthcare management. The Parliamentary and Health Service Ombudsman, Rob Behrens, said that radical reform of NHS management was needed to prevent similar failures. Dewi Evans called for an investigation into potential corporate manslaughter in relation to the case. Dame Ruth May, NHS England's Chief Nursing Officer, stated that the NHS was committed to learning from the case and welcomed the independent inquiry announced by the Department of Health and Social Care. On 21 August 2023, it was announced that the nursing director at the Countess of Chester Hospital during Letby's employment had been suspended from her subsequent role at Northern Care Alliance NHS Foundation Trust, following information that emerged during the trial. The Nursing and Midwifery Council later confirmed that she would face a fitness‑to‑practise investigation. She and other senior executives at the hospital were accused of failing to act on warnings about Letby.
Sources: en.wikipedia.org
A series of four lectures, given by Thomson on a visit to Princeton University in 1896, were subsequently published as Discharge of electricity through gases (1897). He also presented a series of six lectures at Yale University in 1904.
== History == MrMed was conceived in August 2020 when Devashish Singh and Saurab Jain noticed challenges in specialty medicines. Despite facing initial setbacks due to the COVID Delta wave in India, which prompted the founders and their team to prioritize community assistance, MrMed was officially launched in June 2021. The company launched its mobile app in March 2023 for access to speciality medicines for conditions such as cancer, transplants, kidney, or liver diseases. It also raised $500,000 in funding from the Tamil Nadu Emerging Sector Seed Fund (TNESSF) and angel investors. On 8 December 2025, the company announced a strategic partnership with the American multinational pharmaceutical company Eli Lilly to support the distribution of specialty medicines in India.
== See also == Stabilizer (chemistry) – Chemical used to prevent degradation wood preservation – Treatment or process aimed at extending the service life of wood structures food preservation – Inhibition of microbial growth in food
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.